Results 151 to 160 of about 20,520 (215)

Novel 20th century rotavirus alphagastroenteritidis strains identified in formalin-fixed and ethanol-preserved museum specimens. [PDF]

Mol Biol Evol
Porter AF, Holleley CE, Donato CM, Hahn EE, Smith IL, Haff TM, Wilson CA, Alexander MR.   +7 more
europepmc   +1 more source

Hepatic arterial infusion chemotherapy combined with apatinib plus camrelizumab for advanced hepatocellular carcinoma with type Vp4 portal vein tumor thrombosis: a multicenter propensity score-matching analysis. [PDF]

Front Immunol
Wu S, Qiu F, Zhang F, Chen P, Zheng X, Wei Q, Zhang H, Qian C, Shu A, Li M, Xiong D, Zhong S.   +11 more
europepmc   +1 more source

Optimizing methods for virome analysis based on studies of a synthetic viral community. [PDF]

mSystems
Duan J, Marques AD, Hogenauer M, Hwang Y, Zhang Y, Timperman A, Higgins S, Wilson NG, Fitts EA, Lim HK, Bittinger K, Moustafa AM, Collman RG, Bushman FD.   +13 more
europepmc   +1 more source

Regarding: enhancing the BFE-HCC score model: perspectives on methodological advancement and clinical translation. [PDF]

Ann Med
Xu J, Wang G, Chen Z.
europepmc   +1 more source

Minimal Genome, Maximal Effect: How Polyomavirus Genomes Are Capable of Complex Pathogenesis. [PDF]

Viruses
Lano M, Milavetz B.
europepmc   +1 more source

DDX3X Promotes Rotavirus Infection and Serves as an Antiviral Target. [PDF]

Transbound Emerg Dis
Hao P, Liu Y, Cui C, Li L, Qu Q, Shang L, Chen J, Jiang Y, Yin R, Wang J, Wang G, Li C.   +11 more
europepmc   +1 more source

Mapping Molecular Determinants of Antigenicity and Pathogenicity of Infectious Bursal Disease Virus (IBDV): A Scoping Review. [PDF]

Viruses
Tonellato FR, Poletto F, Andolfatto C, Tucciarone CM, Franzo G, Cecchinato M, Legnardi M.   +6 more
europepmc   +1 more source

Molecular mechanisms of protease precursor autoprocessing of RNA viruses: a comprehensive review. [PDF]

Virol J
Mótyán JA, Golda M, Mahdi M, Nashed NT, Louis JM, Tőzsér J.   +5 more
europepmc   +1 more source

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis. [PDF]

Liver Cancer
Chan SL, Kudo M, Sangro B, Kelley RK, Kim JH, Pham B, Hong JY, Waldschmidt DT, Marino D, Joycelyn Lee JX, Gerolami R, Burgoyne AM, Li Q, Nakamura H, Sun P, Baur B, Rimassa L.   +16 more
europepmc   +1 more source

Benchmarks for taxonomic classification of jingmenviruses and closely related viruses using newly identified genomic sequences. [PDF]

J Gen Virol
Colmant AMG, Parry RH, Charrel R, Coutard B.   +3 more
europepmc   +1 more source